Company / Cash per Share
Sunshine Biopharma Inc. Cash per Share History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$8.42
FY2022
5-year range
$1.18 / $8.42
FY2018-FY2022
Trend
+613.4%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share changed +613% YoY in FY2022, a notable deviation from the 6-year average annual change of +1140%.
Based on SEC 10-K filings.
8.42 in FY2022 with a 5-year CAGR of +803.7%.
Improved from $0.03 to $8.42 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +862.1%
- 5-Year CAGR
- +803.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- Sunshine Biopharma Inc.'s cash per share has grown for 5 consecutive years.
- In FY2022, cash per share increased 613.4% year-over-year.
- Lowest cash per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $8.42 | +613.4% |
| FY2021 | $1.18 | +4113.0% |
| FY2020 | $0.03 | +196.4% |
| FY2019 | $0.01 | +277.1% |
| FY2018 | $0.00 | +1694.6% |
| FY2017 | $0.00 | -51.8% |
| FY2016 | $0.00 | -58.0% |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026